References
- Ang KK, Harris J, Wheeler R, et al (2010). Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med, 363, 24-35. https://doi.org/10.1056/NEJMoa0912217
- Chaturvedi AK, Engels EA, Pfeiffer RM, et al (2011). Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol, 29, 4294-301. https://doi.org/10.1200/JCO.2011.36.4596
- Gillison ML, Shah KV (2001). Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol, 13, 183-8. https://doi.org/10.1097/00001622-200105000-00009
- D'Souza G, Kreimer AR, Viscidi R, et al (2007). Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med, 356, 1944-56. https://doi.org/10.1056/NEJMoa065497
- Gillison ML, D'Souza G, Westra W, et al (2008). Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst, 100, 407-20. https://doi.org/10.1093/jnci/djn025
- Huang H, Zhang B, Chen W, et al (2012). Human papillomavirus infection and prognostic predictors in patients with oropharyngeal squamous cell carcinoma. Asian Pac J Cancer Prev, 13, 891-6. https://doi.org/10.7314/APJCP.2012.13.3.891
- Hobbs CG, Sterne JA, Bailey M, et al (2006). Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol, 31, 259-66. https://doi.org/10.1111/j.1749-4486.2006.01246.x
- Huang SH, Perez-Ordonez B, Liu FF, et al (2012). Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys, 82, 276-83. https://doi.org/10.1016/j.ijrobp.2010.08.031
- Kreimer AR, Clifford GM, Boyle P, et al (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev, 14, 467-75. https://doi.org/10.1158/1055-9965.EPI-04-0551
- Klussmann JP, Weissenborn SJ, Wieland U, et al (2001). Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer, 92, 2875-84. https://doi.org/10.1002/1097-0142(20011201)92:11<2875::AID-CNCR10130>3.0.CO;2-7
- Mork J, Lie AK, Glattre E, et al (2001). Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med, 344, 1125-31. https://doi.org/10.1056/NEJM200104123441503
- Romanitan M, Nasman A, Ramqvist T, et al (2008). Human papillomavirus frequency in oral and oropharyngeal cancer in Greece. Anticancer Res, 28, 2077-80.
- Smith EM, Ritchie JM, Summersgill KF, et al (2004). Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer, 108, 766-72. https://doi.org/10.1002/ijc.11633
- Sturgis EM, Ang KK (2011). The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J Natl Compr Canc Netw, 9, 665-73.
- Nasman A, Attner P, Hammarstedt L, et al (2009). Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer, 125, 362-6. https://doi.org/10.1002/ijc.24339
Cited by
- Lack of Association between High-risk Human Papillomaviruses and Oral Squamous Cell Carcinoma in Young Japanese Patients vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4135
- Significance of p16 Positive Expression in Oropharyngeal Cancers vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10289
- Patients' preferences concerning follow‐up after curative head and neck cancer treatment: A cross‐sectional pilot study pp.1097-0347, 2019, https://doi.org/10.1002/hed.25686